{
  "ptid_time": "024_S_4223_2011-09-12",
  "img_path": "/data/qiuhui/data/adni/images/024_S_4223/2011-09-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,262 mm³, 59.1% above the reference mean. With a Z-score of 1.41 (92.1th percentile), this represents mild enlargement; hippocampal volume measures 6,353 mm³, 16.0% below the reference mean. With a Z-score of -1.56 (6.0th percentile), this represents moderate atrophy; whole brain volume measures 1,135,360 mm³, 5.2% above the reference mean. With a Z-score of 0.67 (75.0th percentile), this represents normal volume ; entorhinal cortex volume measures 3,690 mm³, 10.0% below the reference mean. With a Z-score of -0.68 (24.9th percentile), this represents normal volume ; fusiform gyrus volume measures 18,518 mm³, 1.7% below the reference mean. With a Z-score of -0.14 (44.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,179 mm³, 8.6% above the reference mean. With a Z-score of 0.78 (78.1th percentile), this represents normal volume . ",
  "text_data": "Age is 75.8 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Smoking. MMSE: 23.0. MoCA: 9.0. Logical Memory: 3.0. Laboratory findings: Platelets: 112.00 (significant reduced); Neutrophils: 78.40 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.12 SUVR (normal ); Amyloid beta: 834.60 pg/mL (normal ); Total tau: 286.50 pg/mL (normal ); Phosphorylated tau: 23.49 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate hippocampal atrophy (Z-score -1.56, 6th percentile) and mild ventricular enlargement, both suggestive of neurodegeneration. However, CSF biomarkers (Aβ, T-tau, P-tau) and amyloid PET (AV45) are normal, ruling out Alzheimer’s pathology. The low MoCA (9/30) and borderline MMSE (23/30) indicate cognitive impairment, but the lack of biomarker support suggests a non-AD etiology (e.g., vascular, LATE, or other neurodegenerative process).  \n\n**Diagnosis:** **Dementia** (likely non-Alzheimer’s type)  \n**Confidence:** **Medium** (cognitive scores and hippocampal atrophy support dementia, but normal biomarkers reduce certainty about the underlying cause).  \n\n---  \n*Key points:*  \n- **Hippocampal atrophy + cognitive deficits = dementia**, but not AD due to normal biomarkers.  \n- **Low MoCA (9)** is severe and inconsistent with MCI.  \n- **Medium confidence** due to unclear etiology (e.g., vascular, LATE, or mixed pathology).",
  "timestamp": "2025-07-26T03:19:56.793077"
}